Anthem Biosciences
ANTHEMNSE

Anthem Biosciences

₹653.60-12.10 (1.82%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
648.25
Today’s high
657.80
52 week low
579.15
52 week high
873.50
Open price
652.00
Previous close
665.70
Live volume
12,452
Lower circuit
532.60
Upper circuit
798.80

Fundamentals

Market Cap
₹37,469Cr
ROE
18.75%
P/E Ratio(TTM)
77.29
EPS(TTM)
8.63
P/B Ratio
13.61
Dividend Yield
0.00%
Industry P/E
31.44
Book Value
49.00
Debt to Equity
0.04
Face Value
2

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Anthem Biosciences Limited is a contract research and manufacturing services (CRAMS) organization serving pharmaceutical and biotechnology companies.;
MD/CEO
--
Founded in
2006
NSE symbol
ANTHEM
Industry

Shareholding Pattern

Dec '24
Jul '25
Sep '25
Dec '25
Promoters
74.69%
Retail And Others
13.61%
Mutual Funds
6.89%
Foreign Institutions
4.11%
Other Domestic Institutions
0.71%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹1,658.50
-70.00 (4.05%)
L
    H
    4,14,713.0537.865.33
    ₹3,905.90
    -205.40 (5.00%)
    L
      H
      1,39,052.0061.216.46
      LupinLUPIN
      ₹2,186.50
      -88.40 (3.89%)
      L
        H
        1,03,944.2422.265.29
        ₹1,189.40
        -20.20 (1.67%)
        L
          H
          1,00,926.7218.272.8
          Livesquawk
          Anthem Biosciences' Q3 EBITDA stood at 1.57B, down from 1.6B YoY. EBITDA margin improved to 37.2% from 32.0% YoY, reflecting better profitability.
          2026
          5
          Feb
          Quarterly Result
          Release date
          2025
          8
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks